ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...

Record Inventory Increase Meets Growing Consumer Demand for Healthcare Cost-Saving SolutionsSurge Driven by Ozempic and Zepbound Prescription ...

Sahil Bloom, New York Times bestselling author of “The 5 Types of Wealth: A Transformative Guide to Design Your Dream Life,” joins TODAY to share advice for building “wealth” in your life beyond money ...

Researchers at San Jose State University are looking at the benefits of taking a power nap and finding that it can improve brain function, including boosting alertness, mood, memory and more — but how ...

In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...